Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Pituitary
Published in: Pituitary 3/2001

01-08-2001

Minor Tumour Shrinkage in Nonfunctioning Pituitary Adenomas by Long-Term Treatment with the Dopamine Agonist Cabergoline

Authors: Tobias Lohmann, Christoph Trantakis, Markus Biesold, Sascha Prothmann, Steffen Guenzel, Ralf Schober, Ralf Paschke

Published in: Pituitary | Issue 3/2001

Login to get access
Metadata
Title
Minor Tumour Shrinkage in Nonfunctioning Pituitary Adenomas by Long-Term Treatment with the Dopamine Agonist Cabergoline
Authors
Tobias Lohmann
Christoph Trantakis
Markus Biesold
Sascha Prothmann
Steffen Guenzel
Ralf Schober
Ralf Paschke
Publication date
01-08-2001
Publisher
Kluwer Academic Publishers
Published in
Pituitary / Issue 3/2001
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1023/A:1015366923810

Other articles of this Issue 3/2001

Pituitary 3/2001 Go to the issue

OriginalPaper

The Association of Cushing's Disease and Primary Empty Sella Turcica

OriginalPaper

Gender and Age in the Biochemical Assessment of Cure of Acromegaly

OriginalPaper

Effectiveness of Long-Acting Octreotide in Suppressing Hormonogenesis and Tumor Growth in Thyrotropin-Secreting Pituitary Adenomas: Report of Two Cases

OriginalPaper

Short Procedure of GHRH Plus Arginine Test in Clinical Practice

Legacy

Sarcoidosis within a Pituitary Adenoma

Legacy

Uncommon Clinical Course of Multiple Osteochondromatosis in a Patient with a Long-Term History of Cushing's Disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits